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impaired renal function hould not be treated with any long-
acting sulphonamide, including Bayrena.
Presentation. Bayrena is available in tablets of 0·5 G. each.
It is supplied in boxes of 8 and 40 tablets.
Further particulars can be obtained from the sole distri-
butor in South Africa, Messrs. FBA Pharmaceuticals (S.A.)
(Pty) Ltd., P.O. Box 10233, Johannesburg.
LUCOFE TABLETS
Warner Pharmaceuticals (pty.) Ltd. announce the introduction
of Lucofen Tablets, and supply the following information:
A new approach to the treatment of obesity is afforded by
Lucofen, which promotes a feebng of satiety earlier than
usual at meal times, while iilltial appetite is not affected.
Description. Lucofen (chlorphentermine) or l(p-cWorophenyl)
2-methyl-2-aminopropane hydrochloride, is a substance with
practically no central stimulating effect and no significant
sympathomimetic or pressor effect. Patients are calm and co-
operate in dietary control. Weight loss is gradual, being I lb.
. - It lb. per week.
Safe for pregnant patients and cardiacs, Lucofen has not
been shown to cause any measure of addiction or any type of
mental disturbance.
Side-effects. Occasional dryness of the mouth and dy pepsia.
Dosage. I tab. t.i.d. with meals.
Presentation. Bottles of 50 sugar-coated tablets, obtainable
on prescription only.
Further information may be obtained from Warner Pharma-
ceuticals (Pty.) Ltd., 6 - 10 Searle Street, Cape Town.
PROSTAPHLI
Bristol Laboratories announce the introduction of Pro taphlin,
and supply the following information:
Prostaphlin is the third member of a series of synthetic
penicillins produced by Bristol Laboratories for the therapy
of infectious diseases.
The practical production of synthetic-penicillins was initiated
in 1958 when a team of British investigators reported that they
had succeeded in stopping the natural fermentation process of
penicillin at a point where only the 6-amino penicillanic acid
nucleus was present in the broth.
After extraction, the 6-APA nucleus now could serve as the
foundation for the synthesis of countless penicillins with diverse
organic side chains. Among the first derivatives which were
synthesized by Bristol Laboratories were phenoxyethyl penicilJjn,
known generically as phenethicilbn; and the first synthetic peni-
cillin to be produced commercially at Bristol's, Syncilbn, intro-
duced a an oral tablet in October 1959.
The next goal was to look for a 6-APA derivative which, by
virtue of its chemical configuration, would have a bactericidal
effect on staphylococcus aureus, and not be susceptible to in-
activation by staphylococcal penicillinase. The first proved to
be sodium dimethoxyphenyl penicillin, generically called
methicilbn and introduced in October 1960 by Bristol Labora-
tories as Staphcillin. It must be given by injection since it is
destroyed by the acid of the stomach.
TOW a new synthesized penicillin, Prostaphlin, has been
developed. Prostaphbn is not only resistant to staphylococcal
penicillinase, it also has enough resistance to acid hydrolysis
to allow adequate blood levels to be achieved by oral dosage.
In addition, Prostaphlin, microgram for microgram, in labora-
tory studies is more potent than Staphcillin as an antistaphy-
lococcal agent.
Further information is obtainable from BL Pharmaceuticals
(Pty.) Ltd., P.O. Box 2515 Johannesburg.
TlTRALAC
Riker Laboratories announce the introduction of Titralac and
- supply the following information:
Titralac is now available in tablet form in Southern Africa.
Titralac is an antacid with pronounced advantages over other
forms of similar treatment. .
Description. First, and most important, it greatly encourages
cooperation of the patient since the product is so pleasant-
tasting as to be able to pass for a sweet. There is no grittiness
or chalky taste, the consistency being smooth and creamy with
a refreshing flavour.
Indications. The main indications are peptic ulcer; and
secondary indications are 'heartburn', gastric hyperacidity, either
spontaneous or drug-induced. Titralac has rapid action, giving
rebef within a minute. Action is also sustained, and exceeds
that of other antacids. This extended action often lies between
3 and 4 hours. There are no known contraindications.
Composition. Titralac consists of glycine, 0·18 G. and calcium
carbonate 0'42 G., in each tablet. These two drugs, when
given together in this particular proportion, produce a con-
trolled neutralization which gives the ideal acid-titration curve
typical of milk. Titralac contains neither constipating alumiillum
compounds nor laxative magnesium trisilicate. The glycine is
amphoteric in action, and prevents acid rebound: it will also
correct this mechanism if it has already been induced by
harsher alkalis.
Titralac will not gel or thicken in the stomach, and does
not absorb pepsin or nutrients such as vitamins.
Presentation. Titralac tablets are available in handy pocket
tubes of 10, bottles of 40, and dispensing packs of 300.
Professional bterature and clinical trial material are obtain-
able from Riker Laboratories Africa (pty.) Limited, P.O Box
3388, Cape Town.
BOOK REVIEWS : BOEKBESPREKINGS
A ATOMY AND PHYSIOLOGY FOR RADIOGRAPHERS
Anatomy and Physiology for Radiographers. By C. K. War-
rick, M.B., B.S. (Lond.), M.R.C.S., L.R.C.P., F.R.C.S. (Eng.),
F.F.R., D.M.R. Pp. vi+265. Illustrated. R3.oo. London:
Edward Arnold Publishers Ltd. 1960.
This timely publication closely follows the anatomy and
physiology syllabus for the examination for membership to the
Society of Radiographers of Great Britain (M.S.R.). It will
be equally welcome to those students of the South African
Diploma in Radiography, which is reciprocal with that of
Britain, especially in view of the fact that until very recently
no textbook existed which dealt specifically with the needs of
student radiographers in this field.
The text is clear and concise and generously interspersed
with diagrams. Radiographs accompanied by explanatory line
drawing are particularly welcome.
One small criticism may be offered: the student radiographer,
who is destined for the radiotherapeutic field, will need a more
detailed knowledge of cell structure and the biological effects
of radiation than this book offers.
Apart from this minor consideration, the author ha clearly
pre ented the subject with its relevant details in under 300
pages, thus bringing the book within a very reasonable price
~~. RM~
OXYTOCI
Oxytocin. Ed. by R. Caldeyro-Barcia and H. Heller. Pp.
xxiv & 443. Illustrated. RlO.OO· nett. Oxford: Pergamon
Press. 1961.
This book is a record of the Proceedings of an International
Symposium held in 1959 in Montevideo, the home of the
research unit under Professors Alvarez and Caldeyro-Barcia,
where so much outstanding work on the physiology of the
pregnant human uterus has been done.
At a time when the precise method of administration of
oxytocin and the indications for its use, despite its very wide
application, are subjects on which such widely divergent views
are still held, this symposium is particularly valuable. Con-
tributors include such well-known names as Caldeyro-Barcia,
Csapo, Smyth, and Theobald, and many other research workers
on the pharmacological, biochemical, physiological, endocrino-
logical and cliillcal aspects of oxytocin, as well as oxytocinase
and oxytocic substances other than oxytocin, found in the
erum of humans and a number of experimental animals.
Despite the fac: that much of the work on the pharmaco-
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logical and biochemical aspects of oxytocin presented here is
perhaps not of immediate value to the practising obstetrician,
and also perhaps somewhat beyond his grasp, and despite its
almost prohibitive price, it can be confidently predicted that
all obstetricians will find this a fascinating book.
R.P.D.
LO G-TERM A TICOAGULANT THERAPY
Long-term Anticoagulam Therapy in Angina Pectoris and
Myocardial Infarction. A Clinical trial of intensive versus
moderate treatment. By Christian Frederik Borchgrevink,
M.D. Pp. 52. Illustrated. R2.55. Norway: Oslo University
Press. Obtainable from P. B. Mayer, Box 713, Cape Town.
In this monograph the author compares the effects of intensive
and moderate long-term anticoagulant therapy in 147 patients
with angina pectoris and 56 with myocardial infarction, selected
according to strict criteria, allocated at random to each of the
twO treatment groups and observed for 271 patient-years.
Annual mortality and infarction rates were significantly lower
with intensive (0'7% and 1'4%) than with moderate (6'2% and
10'6%) anticoagulation.
Using the PP method of Owren for control of dosage, the
means of the tests recorde.d in each group were 19% and 58%
respectively, a difference which I consider to be too wide for
a proper evaluation of moderate anticoagulation, since the
reduction of clotting activity obtained in this group was so
light as to be insignificant.
However, the author advocates long-term anticoagulant
therapy, adequately carried out, for patients with coronary
heart disease regardless of the severity of the symptoms.
M.M.S.
THE ISCHAEMIC LIMB
Some Aspects of Obliterative Vascular Disease of the Lower
Limb. By J. A. Gillespie, M.D., Ch.M., F.R.C.S. and D. M.
Douglas, Ch.M., F.R.C.S. Pp. vii + 136. Illustrated. R3.00
net. Postage - 16c. Edinburgh: E. & S. Livingstone Ltd.
1961.
This is an eminently readable monograph. Pathology, clinical
features and special investigations are dealt with in some detail.
The use of vasodilator drugs is discussed at length, and the
author (in keeping with other) conclude that they are value-
less.
A chapter on the effects of chronic arterial ob truction on
local blood flow and blood pres ure add to the understanding
of the basic physiology,
The chief merit of this book is in the section on lumbar
ympathectomy, in which urgical anatomy, choice of case for
operation, technique and follow-up studies are dealt with most
authoritatively. Finally, there i a resume of the modem
approach to the problem by direct arterial urgery - the treat-
ment of choice where feasible.
All tho e interested in the problem of the i chaemic limb
will read this book with benefit.
L.B.
A ATOMY OF THE EYE
Eugene Wolft's Anatomy of the Eye and Orbit. Including
the central connections, development, and comparative
anatomy of the visual apparatus. 5th edition. Revised by
R. 1. Last, M.B., B.S. (Adelaide), ER.C.S. (Eng.). Pp. vii +
500. 438 illustrations. R8.40. London: H. K. Lewis and Co.
1961.
Eugene Wolff's Anatomy of the Eye and Orbit has now
appeared in its fifth edition, edited by Prof. R. 1. Last. Since
its first publication in 1933 it has remained one of the finest
texts on ophthalmic anatomy. Thanks to Professor Last, this
can still be said in 1961.
While he has brought the book up-to-date, the literary style
of Eugene Wolff has been scrupulously maintained so that the
spirit of this great scholar lingers on.
The main additions are on the micro-anatomy of the anterior
chamber and the retina, while the text is littered with the
editor's own observations and beautiful coloured diagrams.
However, it is disappointing that the revolutionary work of
Warwick on the Illrd nerve nucleus has not been included and
that the section on slit-lamp microscopy still does not make
mention of the use of the Hruby lens and the microbiology of
the retina.
This book can, as it was in the past, be strongly recom-





To the Editor: I am sure I am expressing the feeling of many
others when I register my disappointment at the handling of
the recent 'Triumph Herald Competition'. Many of us must
have spent considerable time, effort and ingenuity in compiling
our entries and yet the organizers have not seen fit to announce
the correct order and the winning sentence. All we have had
in your pages and in the lay press has been the name of the
winner, and her ticket number.
As this was (we hope) not a lottery but a competition of
skill, the winning number is of not the slightest interest or
importance, whereas the winning answer is. I know that I,
personally, shall have difficulty in again selling tickets in this






FULL-TIME MEDICAL STAFF A 'D THE MEDICAL
ASSOCIATION
To the Editor: Dr. Randall's letterl on the subject 'Full-time
medical staff and the Medical Association' is inadequately
answered by your Editorial 'The doctor and the Medical Asso-
ciation'.: The main burden of Dr. Randall's complaint is con-
tained in the following sentence from his letter: 'The number
resig!ling from the Association is increasing, and, in my
opllllOn, the reason for this is basically that the Association
has become mainly a trade union, interested in and caring
for the pocket and the future of the private doctor, and offer-
ing very little indeed for the full-time medical officer'.
It is quite true that those elected to the councils of the
Association devote a great deal of time, thought and effort to
the economics of competitive private practice. But it would
be as well if those full-timers who spurn and decry these
efforts realized that their own conditions of service are con-
ditioned directly and indirectly by the competition of the
economic and other opportunities which private practice can
offer. In so far as the Association succeeds in improving the
lot of private practitioners, so it automatically improves the lot
of the full-timers. One has only to study the pattern of the
salaries and conditions of service offered for full-time casualty
and resident, appointments in public hospitals during the past
two decades to apprecIate the force of this argument.
It should also be borne in mind that full-time appointments
rest largely in the hands of government and semi-government
agencies which dictate their own terms regardless of the views
expressed by the organized body of the profession - including
representations made by the full-timers themselves. However,
elementary laws of economics and common sense dictate that
if applicants are to be attracted to these appointments, the
rewards offered - in terms of salary, hours of work, leave,
pensions, status, opportunities for academic advancement and
research, etc. - must add up to better than the applicants can
hope to obtain in competitive practice.
Dr. Randall states: The full-timer asks himself why he
hould pay about R20 a year for the privilege of member hip?'
'ot only full-timers are a king themselves this question! But
